Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Aug 26, 2025

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

Src: coordinating metabolism in cancer.

Sara G Pelaz¹, Arantxa Tabernero²

¹Instituto de Neurociencias de Castilla y León (INCYL), Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Calle Pintor Fernando Gallego 1, Salamanca, 37007, Spain.

|October 10, 2022

Summary

This summary is machine-generated.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Regulation of Metabolism

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cx43 levels guide apicobasal polarity in regenerating airway epithelial cells.

Communications biology·2026

Same author

The Src inhibitor peptide TAT-Cx43<sub>266-283</sub> improves survival in an intracranial murine model of lung cancer brain metastasis.

Neuro-oncology advances·2026

Same author

Single-nucleus RNA sequencing reveals a preclinical model for the most common subtype of glioblastoma.

Communications biology·2025

Same author

EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models.

Neuro-oncology·2024

Same author

Impairment of Autophagic Flux Participates in the Antitumor Effects of TAT-Cx43<sub>266-283</sub> in Glioblastoma Stem Cells.

Cancers·2021

Same author

Connexin43 Region 266-283, via Src Inhibition, Reduces Neural Progenitor Cell Proliferation Promoted by EGF and FGF-2 and Increases Astrocytic Differentiation.

International journal of molecular sciences·2020

The Src oncoprotein regulates cancer cell metabolism, including glucose uptake and glycolysis, to support tumor progression and plasticity. Understanding this link is crucial for developing new cancer therapies.

Area of Science:

Oncology
Molecular Biology
Cancer Metabolism

Background:

Cellular metabolism is critical for cancer cell functions like proliferation and migration.
Src is a key signaling node regulating numerous biological processes, including metabolism.
Dysregulated metabolism is a hallmark of cancer, contributing to tumor growth and progression.

Purpose of the Study:

To summarize recent advancements in understanding Src's role in cancer glucose metabolism.
To elucidate the connection between Src, cancer cell metabolic plasticity, and tumor progression.
To discuss current challenges and future opportunities in this research area.

Main Methods:

Literature review of recent studies on Src and cancer metabolism.
Analysis of signaling pathways regulated by Src impacting metabolic processes.

More Related Videos

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry

Published on: June 9, 2019

Related Experiment Videos

Last Updated: Aug 26, 2025

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry

Published on: June 9, 2019

Integration of data on metabolic plasticity and tumor progression linked to Src activity.

Main Results:

Src influences key metabolic pathways, including glucose uptake, glycolysis, the pentose-phosphate pathway, and oxidative phosphorylation.
Src acts as a central coordinator of metabolic reprogramming in cancer cells.
Src-mediated metabolic regulation is linked to enhanced cancer cell proliferation, migration, and stemness.

Conclusions:

Src plays a pivotal role in fine-tuning cancer cell metabolism to support various oncogenic activities.
Targeting Src offers a potential strategy for modulating cancer cell metabolism and inhibiting tumor progression.
Further research is needed to fully exploit the therapeutic potential of targeting the Src-metabolism axis in cancer.